Roche (OTCMKTS:RHHBY) Hits New 52-Week High – Time to Buy?

Roche Holding AG (OTCMKTS:RHHBY) shares hit a new 52-week high during trading on Thursday . The company traded as high as $58.48 and last traded at $58.3125, with a volume of 321156 shares trading hands. The stock had previously closed at $57.79.

Analyst Upgrades and Downgrades

A number of research analysts have commented on RHHBY shares. Jefferies Financial Group downgraded Roche from a “hold” rating to a “moderate sell” rating in a research note on Monday, October 27th. Barclays raised Roche from an “equal weight” rating to an “overweight” rating in a research note on Tuesday, January 6th. The Goldman Sachs Group upgraded Roche from a “sell” rating to a “hold” rating in a report on Thursday, January 15th. JPMorgan Chase & Co. upgraded Roche from an “underweight” rating to a “neutral” rating in a research note on Monday, December 8th. Finally, Citigroup assumed coverage on Roche in a research note on Tuesday, January 27th. They issued a “buy” rating on the stock. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $57.00.

Roche Stock Up 1.6%

The company has a debt-to-equity ratio of 0.80, a quick ratio of 1.02 and a current ratio of 1.29. The company’s 50 day moving average is $53.19 and its 200 day moving average is $46.33.

Institutional Trading of Roche

Several institutional investors have recently modified their holdings of RHHBY. Oakworth Capital Inc. raised its stake in shares of Roche by 20.8% in the fourth quarter. Oakworth Capital Inc. now owns 1,658 shares of the company’s stock valued at $86,000 after purchasing an additional 285 shares in the last quarter. Diversified Trust Co increased its holdings in Roche by 0.5% in the 3rd quarter. Diversified Trust Co now owns 57,881 shares of the company’s stock valued at $2,363,000 after buying an additional 310 shares during the period. Canopy Partners LLC raised its stake in shares of Roche by 4.9% in the 3rd quarter. Canopy Partners LLC now owns 7,580 shares of the company’s stock valued at $317,000 after buying an additional 352 shares in the last quarter. Everett Harris & Co. CA lifted its holdings in shares of Roche by 3.5% during the 2nd quarter. Everett Harris & Co. CA now owns 11,190 shares of the company’s stock worth $456,000 after acquiring an additional 381 shares during the period. Finally, Fulton Bank N.A. boosted its position in shares of Roche by 4.6% during the 4th quarter. Fulton Bank N.A. now owns 11,659 shares of the company’s stock valued at $604,000 after acquiring an additional 508 shares in the last quarter.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.